Lenalidomide and Chronic Lymphocytic Leukemia

Lenalidomide is an oral immunomodulatory drug used in multiple myeloma and myelodysplastic syndrome and most recently it has shown to be effective in the treatment of various lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. The mechanism of action of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: González-Rodríguez, Ana Pilar, Payer, Angel R., Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Villa-Alvarez, Monica, Gonzalez-García, Esther, Gonzalez, Segundo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3791640/
https://ncbi.nlm.nih.gov/pubmed/24163824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/932010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak